Pinned Tweet
This year I am participating in the Leukemia Lymphoma Society Visionary of the Year campaign. Please consider supporting in any way!
pages.lls.org/voy/msla/nola2…
Another great Hill Day with @ASTCT advocating for NIH funding and authorizing the CW Bill Young Cell Transplantation Program! Always fun to be joined by Nancy and @Hillary_Husband along with the amazing team from @NMDP_advocacy @nmdp_org.
Live from Washington, D.C.! ASTCT and @nmdp_org advocates are getting ready for tomorrow’s Hill Day, where they’ll head to Capitol Hill to meet with lawmakers and advocate for policies that support patients, research and the future of transplantation and cellular therapy.
Always an incredible experience working with @Hillary_Husband along with her donor Rob aka Big Red and Becca from @nmdp_org @NMDP_advocacy advocating for reauthorization of the CW Bill Young Cell Transplantation Program and NCBI to continue life saving transplants!
Clark Alsfeld retweeted
Congrats Rohtesh Mehta!! of @MDAndersonNews on
Unrelated Donor Age and Recipient Outcomes After Posttransplant Cyclophosphamide jamanetwork.com/journals/jam…
Clark Alsfeld retweeted
Out now! 🎉 In this opening segment from an expert panel discussion, Drs. Saeed Sadeghi (@UCLAHealth), @lcalsfeld (@OchsnerHealth), @tomleblancMD (@DukeHealth), and Raji Shameem (@orlandohealth) discuss first-line management for low-risk #MDS.
➡️ buff.ly/41JBrfS
Clark Alsfeld retweeted
In the next #MDS roundtable episode, Drs. Saeed Sadeghi (@UCLAHealth), @lcalsfeld (@OchsnerHealth), @tomleblancMD (@DukeHealth), and Raji Shameem (@orlandohealth) discuss the COMMANDS trial of luspatercept versus epoetin alfa.
➡️ buff.ly/V0VkH5Z
Clark Alsfeld retweeted
We're proud to support @lcalsfeld for LLS Visionary of the Year! ❤️
A true advocate for the cancer community, Clark is making a difference—and there’s still time to support his campaign before June 14!
Donate here: tinyurl.com/calsfeld
#CancerAdvocacy #VisionaryOfTheYear
Clark Alsfeld retweeted
This year I am participating in the Leukemia Lymphoma Society Visionary of the Year campaign. Please consider supporting in any way!
pages.lls.org/voy/msla/nola2…
Always great having you take a trip down the road to visit! @OchsnerCancer @MDAndersonNews
👉👉👉Phenomenal visit meeting with our wonderful multi-disciplinary clinical & research teams at Ochsner MD Anderson Cancer @MDAndersonNews @OchsnerHealth in New Orleans !!! #endcancer #leusm #CancerNetwork #Leadership #CancerResearch 🙌 @doctorpemm
Clark Alsfeld retweeted
Our new @BMTCTN 1703 analysis busts a few myths:
- QOL improved with ptCY
- 🩸Cystitis not worse
- 2yr GRFS superior 42% vs 29%, p=0.001
- ptCY relapse NOT higher
@sghmd @GvHD_Meade TY to Mike Martens for elegant analysis #GvHD #alloHCT #BMT
ascopubs.org/doi/10.1200/JCO…
Clark Alsfeld retweeted
Dive into our on-demand CME roundtable for insights on allogeneic HCT for high-risk patients with MDS. Hear from top hematology/oncology experts on best practices, current research and specific clinical scenarios. Access it now 👉 go.nmdp.org/4fAIUTF
Immensely grateful to have received this award from @NMDP_advocacy @nmdp_org, but even more honored to share it with @Hillary_Husband @NancyOetinger @kramkids who are inspiring so many and increasing access to life-saving transplants #bmtsm #donorleaveact
Clark Alsfeld retweeted
The U.S. House of Representatives unanimously passed the Accelerating Kids' Access to Care Act! The act still needs to pass in the Senate and we need your help. If you haven't yet, message your U.S. Senators urging them to vote yes. ow.ly/h10s50TqtKF
Hill Day 2024 with @ASTCT @NMDP_advocacy advocating for Accelerating Kid's Access to Care Act, Alleviating Barriers for Caregivers Act, and @NIH funding with @asmita_mishraMD, TL, and so many others! #ASTCTHillDay #bmtsm
Clark Alsfeld retweeted
ASTCT Government Affairs Committee and leadership members are preparing to discuss key initiatives and issues with congressional staff members at tomorrow's #ASTCTHillDay
Thank you @nmdp_org for giving us the opportunity to discuss important issues in transplant for #MDS with @warren_fingrut @onyee_c @Taha_CancerDoc hosted by @DrBattiwalla at #SOHO2024 #bmtsm
Clark Alsfeld retweeted
Thank you #SOHO2024 for reuniting us @mahrefat @lcalsfeld it’s been 3 years since we were all sitting in the SCTCT fellows room @MDAndersonNews debating and learning together. We’re missing our 4th co-fellow @AimazAfrough
Clark Alsfeld retweeted
Join us and @ASTCT for our Physician Exchange at #SOHO2024! Hear from our panel of experts on the latest in #MDS research, clinical trials and transplant insights—plus earn 1.0 CME credit!
📅 Sept. 4 | 11:46 a.m.
📍 GRB Convention Center | Room 350F
🔗 bit.ly/4dFAtp6
Very exciting new treatment options for our patients with chronic GVHD! #bmtsm onclive.com/view/fda-approve…


































